Immune Thrombocytopenia (ITP) Clinical Trials

A listing of Immune Thrombocytopenia (ITP) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 59 clinical trials
A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP (XPAG-ITP)

The purpose of this study is to compare the ability of eltrombopag in combination with a short course of high-dose dexamethasone to induce sustained response off treatment in patients with newly-diagnosed ITP versus 1-3 cycles of dexamethasone monotherapy. The unmet clinical need and the potential for eltrombopag when added to …

eltrombopag
dexamethasone
platelet count
  • 20 views
  • 07 Jul, 2022
  • 23 locations
The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia (ITP)

This is a multisite, double-blind, randomized, placebo-controlled, and parallel study designed to evaluate the clinical efficacy and safety of Huaiqihuang granule for treatment to children with chronic primary immune thrombocytopenia (Qi Yin deficiency).

anemia
aptt
autoimmune disease
initial diagnosis
thrombocytopenia
  • 0 views
  • 15 Jul, 2022
  • 14 locations
Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Evaluate the safety and tolerability of avatrombopag given for 90 days after stopping treatment with eltrombopag or romiplostim.

eltrombopag
thrombocytopenia
avatrombopag
romiplostim
  • 0 views
  • 24 Jul, 2022
  • 13 locations
Romiplostim Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

The purpose of this study is to determine the response rate and response duration with the combination of low-dose rituximab, romiplostim and high-dose dexamethasone.

thrombocytopenia
platelet count
dexamethasone
romiplostim
rituximab
  • 0 views
  • 25 Jan, 2021
  • 1 location
Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus (ISOLED)

The study aims at determining if dietary phytoestrogens can be risk factors for Systemic Lupus Erythematosus (SLE). Dietary enquiry and phytoestrogens measurements will be performed in blood and urine of patients with SLE in an active phase of the disease, in patient with other autoimmune diseases and in healthy volunteers. …

autoimmune disease
lupus
Accepts healthy volunteers
  • 53 views
  • 01 Feb, 2022
  • 1 location
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

Immune thrombocytopenia (ITP) is an autoimmune disease but, paradoxically, and unlike other autoimmune diseases, antiplatelet antibodies are not used either for the diagnosis of the disease or

acute leukemia
immune globulin
leukemia
autoimmune disease
thrombocytopenia
  • 0 views
  • 02 Jun, 2021
  • 1 location
Herombopag + rhTPO in Severe Immune Thrombocytopenia

Severe immune thrombocytopenia (ITP) is a life-threatening acquired hemorrhagic disease with dramatically decreased platelet number and clinical bleeding symptoms. Some patients with severe ITP

immunosuppressant
platelet transfusion
eltrombopag
romiplostim
avatrombopag
  • 0 views
  • 18 May, 2022
  • 1 location
Safety and Efficacy of Fecal Microbiota Transplantation

, dysbiotic bowel syndrome, MRSA enteritis, Pseudomembranous enteritis, idiopathic thrombocytopenic purpura (ITP), and atopy. Despite FMT appears to be relatively safe and efficacious in treating a

metabolic syndrome
diabetes mellitus
multiple sclerosis
liver disease
ulceration
  • 427 views
  • 23 Mar, 2022
  • 1 location
Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With Chronic ITP

It is a phase III multicenter randomized double-blinded comparative study of clinical efficacy and safety of GNR-069 and Nplate in patients with chronic idiopathic thrombocytopenic purpura

thrombocytopenia
splenectomy
azathioprine
igiv
platelet count
  • 0 views
  • 25 Mar, 2022
  • 2 locations
Eltrombopag Combined With Low-dose Rituximab in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

This prospective, open-label, nonrandomized, multicenter clinical trial aims at comparing the efficacy and safety of combined use of eltrombopag with low-dose rituximab vs. the best available therapy(BAT)in adult immune thrombocytopenia with autoantibodies fail (due to intolerance or resistance) to first-line treatment.

immunosuppressant
lupus
rituximab
immune tolerance
sjogren's syndrome
  • 0 views
  • 26 May, 2022
  • 1 location